Qi Wang

Qi Wang

Auto-generated profile, based on publicly available information

Qi Wang

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2024 in Journal of Energy Storage
Verified
Journal Article
Closed access
MZMei Zhou
Mei Zhou
YTYe Tan
Ye Tan
RCRong Chen
Rong Chen
YZYou-Tong Zhu
You-Tong Zhu
SCSheng-Ci Cui
Sheng-Ci Cui
JZJu-Lan Zeng
Ju-Lan Zeng

18 October 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
WLWeili Li
Weili Li
WHWenbo Hu
Wenbo Hu
SYShuhua Yuan
Shuhua Yuan
JCJiahao Chen
Jiahao Chen
QWQi Wang
Qi Wang
JHJu Han
Ju Han
BACKGROUND: Recent advancements in animal studies have demonstrated the potential of normobaric hyperoxia (NBO) as a promising intervention for preserving the integrity of the blood–brain barrier (BBB). However, there is still limited understanding of the effects of NBO on BBB function in patients with clinical stroke. Therefore, the objective of this study was to investigate the efficacy of NBO therapy in attenuating BBB damage and reducing brain injury in individuals undergoing endovascular treatment (EVT) for acute stroke. METHODS AND RESULTS: This study enrolled patients from the OPENS‐1 (Normobaric Hyperoxia Combined With Reperfusion for Acute Ischemic Stroke) study, with 43 patients receiving NBO combined with EVT and 43 patients receiving EVT alone. The main outcome measures included serum levels of occludin, MMP‐9 (matrix metalloproteinase‐9), NSE (neuron‐specific enolase), and S100b at 24 hours and 7 days, as well as the intracranial extravasation rate at 24 hours. Serum markers were assessed using ELISA, and intracranial contrast extravasation was visualized using dual‐energy computed tomography scan. We analyzed a total of 86 patients and found that the 24‐hour serum markers levels of BBB damage and brain injury were significantly lower in the group receiving NBO therapy combined with EVT compared with the group receiving EVT alone. Similarly, at 7 days, the levels of occludin, MMP‐9, and NSE were lower in the NBO+EVT group. We also found that the 24‐hour serum levels of occludin and MMP‐9 were correlated with intracranial contrast extravasation. Additionally, the incidence of intracranial contrast extravasation was lower in the NBO+EVT group compared with the EVT group (35.9% versus 60.5%, P =0.031). CONCLUSIONS: This study offers valuable insights into the positive impact of NBO on maintaining BBB integrity and reducing brain injury in patients with acute stroke undergoing EVT.

17 June 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
SXShuaili Xu
Shuaili Xu
QWQi Wang
Qi Wang
HAHong An
Hong An
HWHao Wang
Hao Wang
QFQiang Fang
Qiang Fang
DWDi Wu
Di Wu
Hypothermia and hypometabolism are important for hibernating animals to survive harsh environmental conditions. Induction of a hypothermic and hypometabolic state is considered an avenue to treat severe diseases, such as ischemic stroke. However, noninvasive and safe methods to achieve a long-lasting hypothermic and hypometabolic state remain limited. Here, we present data from preclinical and clinical studies to explore the feasibility and safety of drug-induced hypothermia by administration of chlorpromazine and promethazine (C+P). In mice, C+P treatment induced hypothermia and suppressed glucose metabolism in the brain. C+P treatment reduced infarct volumes and improved neurological deficit in a mouse middle cerebral artery occlusion model induced by suture insertion. Furthermore, C+P treatment reduced body temperature, suppressed metabolism, and exerted cerebroprotective effects in a rhesus monkey model of stroke. In a double-blind, phase 1 clinical trial (NCT06663631), a total of 32 patients diagnosed with acute ischemic stroke were enrolled, receiving either placebo or increasing doses of C+P treatment: 10, 20, 50, or 100 milligrams. All doses were safe and well tolerated. Only 100 milligrams of C+P resulted in a modest and transient reduction in body temperature. Plasma proteomic profiling revealed a down-regulation of markers associated with aerobic respiration and glucose metabolism. These findings highlight the translational potential of C+P treatment and warrant a larger trial to further investigate safety and efficacy of C+P.

8 September 2023
Verified
Conference Paper
Closed access
XPXianxian Pan
Xianxian Pan
QWQi Wang
Qi Wang
PLPandeng Luo
Pandeng Luo
BZBing Zhao
Bing Zhao
Jie HaoJie Hao
Jie Hao
HYHao Yu
Hao Yu
In this paper, firstly, based on the domestic and international short-circuit current calculation standards, the current situation of short-circuit current calculation on load at home and abroad is analyzed, then the conventional calculation method of short-circuit current is introduced, then the process of induction motor affecting short-circuit current in transmission network is analyzed, then the influence of variable frequency load plus motor on short-circuit current is analyzed, then the influence of electrolytic aluminum load on short-circuit current is studied, and finally the influence of comprehensive load model considering induction motor on short-circuit current is analyzed.

1 January 2024 in Int. Journal of Clinical Pharmacology and Therapeutics
Verified
Journal Article
Closed access
HZHong Zhang
Hong Zhang
LCLei Chen
Lei Chen
XWXiao-Ying Wang
Xiao-Ying Wang
QWQi Wang
Qi Wang
GLGuang-Li Li
Guang-Li Li
XWXiaojuan Wang
Xiaojuan Wang
This study aimed to explore the risk factors of hypoglycemia in patients with gastrointestinal bleeding caused by somatostatin for injection and to establish a prediction model based on logistic regression combined with receiver operating characteristic (ROC) curve. This retrospective study analyzed patients diagnosed with gastrointestinal bleeding and treated with somatostatin from January 2022 to May 2023 and collected hypoglycemic events. Univariate and multivariate logistic regression analysis were used to determine the independent influencing factors of somatostatin-induced hypoglycemia, and a prediction model was established. ROC analysis was used to evaluate the prediction model. A total of 331 patients were enrolled in this study, and 42 patients developed hypoglycemic events. Age and co-infection were found to be significant risk factors for hypoglycemia in patients with gastrointestinal bleeding induced by somatostatin. Binary logistic regression fitting established the hypoglycemia prediction model Logit (P) = -4.125+0.053Yage +1.366Yco-infection (co-infection: Xco-infection = 1, non-co-infection: Xno co-infection = 0), Hosmer-Lemeshow test results showed that the model had a good fit (χ2 = 10.552, df = 8, p = 0.228), and the AUC of the prediction model to predict the risk of hypoglycemia caused by somatostatin in patients with gastrointestinal bleeding was 0.744 (95% CI: 0.653 - 0.835, p < 0.001), the sensitivity was 57.14%, and the specificity was 93.77%. Among adult patients with gastrointestinal bleeding treated with somatostatin for injection, our study found that age and co-infection were significant risk factors for somatostatin-induced hypoglycemia in this patient population, and the fitted models had high predictive value in predicting the occurrence of hypoglycemia.